INSIDE PHARMA develops and grows value delivered to its subscribers
A new phase of laser focus begins...
SARS-CoV-2 injections landscape changes
Since INSIDE PHARMA first launched in January 2022, the SARS-CoV-2 injections landscape has changed significantly; at least, so it seems to me.
At that time, censorship of REAL experts was rife, misinformation was being peddled through every conceivable channel, and there seemed to be no way forward to penetrate the lies and fabrications of Big Pharma, Big Corporations, and Big Tech.
We are still not out of the woods, of course. However, with the release of the Pfizer documents courtesy of a sympathetic judge (his special place is reserved in heaven!), Senator Rand Paul and others publically knocking lumps out of Fauci. Elon Musk buying Twitter, with #BillGatesIsEvil trending regularly, and Brook Jackson, Sasha Latypova, PJH Law, and many others putting their shoulder to the wheel, surely there is room for optimism?
Along with optimism now, me thinks, must follow laser focus on the issues that are going to bring the evil scheming slugs down to earth. That is why I have revisited INSIDE PHARMA’s mission going forward, to:
INSIDE PHARMA - Sharing totally unique insights on the pharma industry, along with practical ways to reform it, based on indisputable facts, evidence and education.
The ABOUT page is also revisited, as so:
INSIDE PHARMA—what’s in it for you?
‘YOU’ will be a critical thinker on the medicines, medical devices, diagnostic tests, and any other allegedly therapeutic products, that you, your loved ones, friends and colleagues may be offered or exposed to.
Critical thinking means unfettered access to facts, evidence and deep, inside knowledge. MSN fed propaganda is not what you are looking for—you want to hear the truth, and that’s what you will get here.
Who is behind it?
It’s me, Hedley Rees.
During August 2021, I was expelled from LinkedIn, where I had been well regarded as the voice of radical change for the pharma industry. Open minded people there valued my vision of an industry where patients and healthcare professionals were central to medical progress. The ones that didn’t orchestrated my permanent removal.
My bio reads like this:
Hedley Rees is the Managing Consultant at PharmaFlow Limited (2005), a UK based consultancy specializing in operations and supply chain management within the pharmaceutical and life science sectors.
Clients range from large pharmaceutical companies to emerging biotech, and also include investors, lawyers, other consultancies, facility design & build specialists and third-party logistics providers (3PLs).
Assignments span preclinical, clinical, and commercial supply chains up to complex multi-product networks covering global territories.
Qualifications: B. Eng. (Tech) Hons Production Engineering, University of Wales; Executive MBA, Cranfield University School of Management.
Previous Appointments: Senior positions at Bayer UK, British Biotech, Vernalis, Ortho-Clinical Diagnostics and OSI Pharmaceuticals (now Astellas).
Affiliations and qualifications:
Advisory Board Member, International Institute, Advanced Purchasing & Supply (IIAPS).
Editorial Board Member and contributor, GMP Review (GMP = Good Manufacturing Practice).
Former consultant to Oxford BioMedica on UK Government funding call AdvancedManufacturing Supply Chain Initiative (AMSCI), resulting in funding of £7.1M
Former Advisory Board Member to Marken, 2011 - 2012 (now a UPS company).
Founding Member of Expert Industry Panel for CPhI Worldwide (UBM plc)
Former member of the UK Bio-Industry Association’s (BIA) Manufacturing Advisory Committee, 2007 – 2011
What will INSIDE PHARMA give you access to?
Hedley’s 40+ years experience working in the industry as a consultant and leader in drug development and commercial supply chains, including vaccines.
Easy to understand virtual learning on industry fundamentals, based on Hedley’s progamme for the University of South Wales School of Applied Sciences, titled The Pharmaceutical Industry and Evidence-Based Healthcare, described in this introductory video
Interviews with hand-picked experts from Hedley’s vast network of contacts who are working diligently to course-correct the downward spiral that is the Big Pharma modus operandi. Brook Jackson and Sasha Latypova are examples.
And much more - check out the archives to fill your boots with the possibilities!
What else is being revisited?
I have become a pharma outcast, who wasn’t very popular in the first place with the greedy inhabitants remaining (former clients), who prefer to cut corners and twist the truth. I’ve therefore switched on paid subscriptions in the last few weeks.
The increased focus above aims to deliver value that far exceeds the monthly subscription of $5 (minimum Substack allows).
Cheers for now, Hedley
INSIDE PHARMA is a reader-supported publication. To receive new posts and support my work, consider becoming a free or paid subscriber.